Company / Shareholders' Equity
IONIS PHARMACEUTICALS INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$489.1M
FY2025
5-year range
$386.7M / $743.3M
FY2021-FY2025
Trend
-16.9%
vs FY2024
Sector context
#97 of 213
Health Care
What the data says
At $489M, IONIS PHARMACEUTICALS INC's shareholders' equity ranks #97 of 213 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $100M in FY2016 to $1.5B in FY2019.
Based on SEC 10-K filings.
$489M in FY2025 with a 5-year CAGR of -10.3%.
Improved from $387M to $489M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -5.1%
- 5-Year CAGR
- -10.3%
- 10-Year CAGR
- -
Sector benchmark
#97 of 213 in Health CareTop 46% of 213This company $489.1M Sector average $2.5B
▼
-80.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.3%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 16.9% year-over-year.
- Ranks #97 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $489.1M | -16.9% |
| FY2024 | $588.4M | +52.2% |
| FY2023 | $386.7M | -32.5% |
| FY2022 | $572.9M | -22.9% |
| FY2021 | $743.3M | -11.9% |
| FY2020 | $843.3M | -42.7% |
| FY2019 | $1.5B | +40.4% |
| FY2018 | $1.0B | +273.0% |
| FY2017 | $281.0M | +182.2% |
| FY2016 | $99.6M | -50.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026